Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) - Global Forecast to 2024

解剖病理学の世界市場予測:機器(組織処理システム、ミクロトーム)、消耗品(抗体)、組織病理学

◆タイトル:Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) - Global Forecast to 2024
◆商品コード:MD5104
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年10月30日
◆ページ数:195
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は、解剖病理学の世界市場規模が2019年330億ドルから2024年444億ドルまで年平均6.1%成長すると予測しています。当調査レポートでは、解剖病理学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品&サービス別(機器(組織処理システム、ミクロトーム)、消耗品(抗体)、組織病理学)分析、用途別(病気診断(がん(消化管))分析、エンドユーザー別(病院、ラボ)分析、解剖病理学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“High incidence of cancer & other target diseases, availability of reimbursement, and the growing focus on personalized medicine are driving the overall growth of the anatomic pathology market”The anatomic pathology market is projected to reach a value of USD 44.4 billion by 2024 from USD 33.0 billion in 2019, at a CAGR of 6.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper market growth to a certain extent in the coming years.

“Disease diagnosis segment accounted for the larger share of the anatomic pathology market, by application, in 2018”
Based on application, the anatomic pathology market is segmented into disease diagnosis and medical research. In 2018, the disease diagnosis segment accounted for the larger market share, due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

“Hospital laboratories to register the highest growth in the anatomic pathology market during the forecast period”
Based on end user, the anatomic pathology market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2018 and is projected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing number of patient visits to hospitals, growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

“North America will continue to dominate the anatomic pathology market during the forecast period”
Geographically, the anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%, Tier 2 – 45%, and Tier 3 – 19%
• By Designation: C-level – 33%, D-level – 40%, and Others – 27%
• By Region: North America – 36%, Europe – 28%, Asia Pacific – 19%, and the Rest of the World – 17%

List of Companies Profiled in the Report
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Thermo Fisher Scientific (US)
• Hologic, Inc. (US)
• Agilent Technologies (US)
• Becton, Dickinson and Company (US)
• Sakura Finetek (Japan)
• Merck KGaA (Germany)
• Bio SB (US)
• Diapath S.p.A. (Italy)
• BioGenex Laboratories (US)
• Abcam (US)
• Milestone Medical (Italy)
• SLEE medical (Germany)
• Histo-Line Laboratories (Italy)
• Amos Scientific (Australia)
• Jinhua YIDI Medical Appliance Co. Ltd. (China)
• MEDITE GmbH (Germany)
• Cell Signaling Technology (US)
• CellPath (UK)

Research Coverage:
This report provides a detailed picture of the global anatomic pathology market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall anatomic pathology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

【レポートの目次】

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 25)
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.1.1 Bottom-Up Approach for the Instruments and Consumables Market
2.4.2 Top-Down Approach
2.4.2.1 Services Market Estimation Based on Number of Tests
2.4.2.2 Services Market Estimation Based on Procedures
2.4.3 Growth Forecast
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary (Page No. – 33)
3.1 Introduction
4 Premium Insights (Page No. – 37)
4.1 Anatomic Pathology: Market Overview
4.2 North America: Anatomic Pathology Market, By Product & Service
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Cancer and Other Target Diseases
5.2.1.2 Recommendations for Cancer Screening
5.2.1.3 Availability of Reimbursement
5.2.1.4 Growing Focus on Personalized Medicine
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.3 Challenges
5.2.3.1 Availability of Refurbished Products
5.2.3.2 Lack of Skilled Professionals
5.2.3.3 Product Failures and Recalls
5.2.4 Trends
5.2.4.1 Reagent Rental Agreements
6 Anatomic Pathology Market, By Product & Service (Page No. – 45)
6.1 Introduction
6.2 Services
6.2.1 Histopathology
6.2.1.1 the Majority of Cancers are Diagnosed Via Histopathology—A Key Factor Driving Market Growth
6.2.2 Cytopathology
6.2.2.1 Government Focus on Cervical Cancer Screening has Boosted the Growth of the Cytopathology Services Market
6.3 Consumables
6.3.1 Antibodies
6.3.1.1 Primary Antibodies
6.3.1.1.1 North America Dominates the Primary Antibodies Market
6.3.1.2 Secondary Antibodies
6.3.1.2.1 Asia Pacific Will Show the Highest Growth in the Market for Secondary Antibodies
6.3.2 Kits & Reagents
6.3.2.1 Stains & Solvents
6.3.2.1.1 North America Accounted for Highest Share in This Market
6.3.2.2 Fixatives
6.3.2.2.1 North America Accounts for the Largest Share of the Fixatives Market
6.3.2.3 Other Kits & Reagents
6.3.3 Probes
6.3.3.1 APAC is Expected to Show the Highest Growth in the Probes Market
6.3.4 Other Consumables
6.4 Instruments
6.4.1 Slide Staining Systems
6.4.1.1 Availability of Automated Systems Will Drive Market Growth During the Forecast Period
6.4.2 Tissue Processing Systems
6.4.2.1 Rising Adoption of Automation is a Key Trend in the Tissue Processing Systems Market
6.4.3 Cell Processors
6.4.3.1 Cell Processors are Used to Remove Unwanted Matter in Samples—Making Them Important Instruments in the Market
6.4.4 Microtomes
6.4.4.1 North America Accounts for the Largest Share of the Microtomes Market
6.4.5 Embedding Systems
6.4.5.1 Asia Pacific is Expected to Register the Highest Growth During the Forecast Period
6.4.6 Coverslippers
6.4.6.1 Coverslippers are Widely Used Instruments in Research Alongside Staining Systems
6.4.7 Other Instruments
7 Anatomic Pathology Market, By Application (Page No. – 60)
7.1 Introduction
7.2 Disease Diagnostics
7.2.1 Cancer
7.2.1.1 Breast Cancer
7.2.1.1.1 Breast Cancer Holds the Highest Mortality Rate Among Cancers in North America
7.2.1.2 Gastrointestinal Cancer
7.2.1.2.1 North America Accounts for the Largest Share of the Market for Gastrointestinal Cancer
7.2.1.3 Lung Cancer
7.2.1.3.1 Lung Cancer is the Most Common Cancer in the World
7.2.1.4 Prostate Cancer
7.2.1.4.1 Prostate is the Third-Leading Cause of Death By Cancer in North America
7.2.1.5 Other Cancers
7.2.2 Other Diseases
7.3 Medical Research
7.3.1 Growing Research Activities Will Drive the Adoption of Anatomic Pathology Products in This Application Segment
8 Anatomic Pathology Market, By End User (Page No. – 69)
8.1 Introduction
8.2 Hospital Laboratories
8.2.1 Hospital Laboratories Accounted for the Largest Share of the Market
8.3 Clinical Laboratories
8.3.1 Increasing Outpatient Surgeries to Drive the Growth of This Segment
8.4 Other End Users
9 Anatomic Pathology Market, By Region (Page No. – 74)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the Global Market
9.2.2 Canada
9.2.2.1 High Burden of Cancer to Support Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Availability of Reimbursement for Colorectal Cancer Screening to Support Market Growth
9.3.2 France
9.3.2.1 Government Funding for Cancer Diagnosis & Prevention to Support Market Growth
9.3.3 UK
9.3.3.1 Government Initiatives to Drive Market Growth in the UK
9.3.4 Italy
9.3.4.1 High Incidence of Cancer and Increasing Per Capita Healthcare Spending to Support Market Growth in Italy
9.3.5 Spain
9.3.5.1 High Incidence of Chronic Diseases to Drive the Spanish Market
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Presence of a Well-Developed Healthcare System to Support Market Growth in Japan
9.4.2 China
9.4.2.1 Rising Healthcare Expenditure to Drive the Market Growth
9.4.3 India
9.4.3.1 Growing Healthcare Sector in the Country to Drive Market Growth
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Cancer Screening Programs to Support Market Growth
9.5.2 Middle East & Africa
9.5.2.1 Increasing Incidence of Cancer in Africa to Support Market Growth
10 Competitive Landscape (Page No. – 143)
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.3.1 Agreements & Partnerships (2016–2019)
10.3.2 Expansions (2016–2019)
10.3.3 Product Launches & Approvals (2016–2019)
10.3.4 Acquisitions (2016–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Innovators
10.4.4 Dynamic Differentiators
10.4.5 Emerging Companies
11 Company Profiles (Page No. – 150)
11.1 F. Hoffman-La Roche Ltd.
11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 MnM View
11.2 Danaher
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Thermo Fisher Scientific
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.3.4 MnM View
11.4 Abcam PLC.
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.5 Hologic, Inc.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.6 Agilent Technologies
11.6.1 Business Overview
11.6.2 Products Offered
11.7 Becton, Dickinson and Company
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.7.4 MnM View
11.8 Sakura Finetek USA Inc.
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.9 Merck KGaA
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.10 Bio SB
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.11 BioGenex
11.11.1 Business Overview
11.11.2 Products Offered
11.12 Milestone Medical
11.12.1 Business Overview
11.12.2 Products Offered
11.13 Histo-Line Laboratories
11.13.1 Business Overview
11.13.2 Products Offered
11.13.3 Recent Developments
11.14 Diapath S.P.A.
11.14.1 Business Overview
11.14.2 Products Offered
11.14.3 Recent Developments
11.15 Slee Medical GmbH
11.15.1 Business Overview
11.15.2 Products Offered
11.16 Amos Scientific Pty Ltd
11.16.1 Business Overview
11.16.2 Products Offered
11.17 Medite GmbH
11.17.1 Business Overview
11.17.2 Products Offered
11.18 Cell Signaling Technology
11.18.1 Business Overview
11.18.2 Products Offered
11.18.3 Recent Developments
11.19 CeLLPath Ltd.
11.19.1 Business Overview
11.19.2 Products Offered
11.20 Jinhua Yidi Medical Appliance Co. Ltd
11.20.1 Business Overview
11.20.2 Products Offered
12 Appendix (Page No. – 186)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (232 Tables)
Table 1 Global Cancer Incidence, 2018 Vs. 2025
Table 2 Growth in the Number of Personalized Medicines, 2008–2016
Table 3 Number of Pathologists Per 100,000 Population, By Country, 2018
Table 4 Anatomic Pathology Market, By Product & Service, 2017–2024 (USD Million)
Table 5 Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 6 Histopathology Services Market, By Region, 2017–2024 (USD Million)
Table 7 Cytopathology Services Market, By Region, 2017–2024 (USD Million)
Table 8 Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 9 Antibodies Market, By Type, 2017–2024 (USD Million)
Table 10 Primary Antibodies Market, By Region, 2017–2024 (USD Million)
Table 11 Secondary Antibodies Market, By Region, 2017–2024 (USD Million)
Table 12 Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 13 Stains & Solvents Market, By Region, 2017–2024 (USD Million)
Table 14 Fixatives Market, By Region, 2017–2024 (USD Million)
Table 15 Other Kits & Reagents Market, By Region, 2017–2024 (USD Million)
Table 16 Probes Market, By Region, 2017–2024 (USD Million)
Table 17 Other Consumables Market, By Region, 2017–2024 (USD Million)
Table 18 Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 19 Slide Staining Systems Market, By Region, 2017–2024 (USD Million)
Table 20 Tissue Processing Systems Market, By Region, 2017–2024 (USD Million)
Table 21 Cell Processors Market, By Region, 2017–2024 (USD Million)
Table 22 Microtomes Market, By Region, 2017–2024 (USD Million)
Table 23 Embedding Systems Market, By Region, 2017–2024 (USD Million)
Table 24 Coverslippers Market, By Region, 2017–2024 (USD Million)
Table 25 Other Instruments Market, By Region, 2017–2024 (USD Million)
Table 26 Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 27 Market for Disease Diagnostics, By Disease Type, 2017–2024 (USD Million)
Table 28 Market for Cancer, By Type, 2017–2024 (USD Million)
Table 29 Breast Cancer Incidence, By Region, 2018 Vs. 2025
Table 30 Market for Breast Cancer, By Region, 2017–2024 (USD Million)
Table 31 Stomach Cancer Incidence, By Region, 2018 Vs. 2025
Table 32 Market for Gastrointestinal Cancer, By Region, 2017–2024 (USD Million)
Table 33 Lung Cancer Incidence, By Region, 2018 Vs. 2025
Table 34 Market for Lung Cancer, By Region, 2017–2024 (USD Million)
Table 35 Prostate Cancer Incidence, By Region, 2018 Vs. 2025
Table 36 Market for Prostate Cancer, By Region, 2017–2024 (USD Million)
Table 37 Market for Other Cancers, By Region, 2017–2024 (USD Million)
Table 38 Market for Other Diseases, By Region, 2017–2024 (USD Million)
Table 39 Market for Medical Research, By Region, 2017–2024 (USD Million)
Table 40 Market, By End User, 2017–2024 (USD Million)
Table 41 Market for Hospital Laboratories, By Region, 2017–2024 (USD Million)
Table 42 Anatomic Pathology Market for Clinical Laboratories, By Region, 2017–2024 (USD Million)
Table 43 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 44 Market, By Region, 2017–2024 (USD Million)
Table 45 North America: Anatomic Pathology Market, By Country, 2017–2024 (USD Million)
Table 46 North America: Market, By Product & Service, 2017–2024 (USD Million)
Table 47 North America: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 48 North America: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 49 North America: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 50 North America: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 51 North America: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 52 North America: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 53 North America: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 54 North America: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 55 North America: Market, By End User, 2017–2024 (USD Million)
Table 56 US: Market, By Product & Service, 2017–2024 (USD Million)
Table 57 US: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 58 US: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 59 US: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 60 US: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 61 US: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 62 US: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 63 US: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 64 US: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 65 US: Market, By End User, 2017–2024 (USD Million)
Table 66 Canada: Key Macroindicators
Table 67 Canada: Market, By Product & Service, 2017–2024 (USD Million)
Table 68 Canada: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 69 Canada: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 70 Canada: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 71 Canada: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 72 Canada: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 73 Canada: Market, By Application, 2017–2024 (USD Million)
Table 74 Canada: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 75 Canada: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 76 Canada: Market, By End User, 2017–2024 (USD Million)
Table 77 Europe: Market, By Country, 2017–2024 (USD Million)
Table 78 Europe: Market, By Product & Service, 2017–2024 (USD Million)
Table 79 Europe: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 80 Europe: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 81 Europe: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 82 Europe: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 83 Europe: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 84 Europe: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 85 Europe: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 86 Europe: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 87 Europe: Market, By End User, 2017–2024 (USD Million)
Table 88 Incidence of Cancer, By Type, 2018 Vs. 2025
Table 89 Germany: Market, By Product & Service, 2017–2024 (USD Million)
Table 90 Germany: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 91 Germany: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 92 Germany: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 93 Germany: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 94 Germany: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 95 Germany: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 96 Germany: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 97 Germany: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 98 Germany: Market, By End User, 2017–2024 (USD Million)
Table 99 Cancer Incidence, By Type, 2018 Vs. 2025
Table 100 France: Market, By Product & Service, 2017–2024 (USD Million)
Table 101 France: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 102 France: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 103 France: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 104 France: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 105 France: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 106 France: Market, By Application, 2017–2024 (USD Million)
Table 107 France: Anatomic Pathology Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 108 France: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 109 France: Market, By End User, 2017–2024 (USD Million)
Table 110 UK: Market, By Product & Service, 2017–2024 (USD Million)
Table 111 UK: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 112 UK: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 113 UK: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 114 UK: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 115 UK: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 116 UK: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 117 UK: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 118 UK: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 119 UK: Market, By End User, 2017–2024 (USD Million)
Table 120 Incidence of Cancer, By Type, 2018 Vs. 2025
Table 121 Italy: Market, By Product & Service, 2017–2024 (USD Million)
Table 122 Italy: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 123 Italy: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 124 Italy: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 125 Italy: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 126 Italy: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 127 Italy: Market, By Application, 2017–2024 (USD Million)
Table 128 Italy: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 129 Italy: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 130 Italy: Market, By End User, 2017–2024 (USD Million)
Table 131 Spain: Market, By Product & Service, 2017–2024 (USD Million)
Table 132 Spain: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 133 Spain: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 134 Spain: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 135 Spain: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 136 Spain: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 137 Spain: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 138 Spain: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 139 Spain: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 140 Spain: Market, By End User, 2017–2024 (USD Million)
Table 141 RoE: Market, By Product & Service, 2017–2024 (USD Million)
Table 142 RoE: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 143 RoE: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 144 RoE: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 145 RoE: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 146 RoE: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 147 RoE: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 148 RoE: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 149 RoE: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 150 RoE: Market, By End User, 2017–2024 (USD Million)
Table 151 Asia Pacific: Anatomic Pathology Market, By Country, 2017–2024 (USD Million)
Table 152 Asia Pacific: Market, By Product & Service, 2017–2024 (USD Million)
Table 153 Asia Pacific: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 154 Asia Pacific: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 155 Asia Pacific: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 156 Asia Pacific: Antibodies Market, By Type 2017–2024 (USD Million)
Table 157 Asia Pacific: Kits & Reagents Market, By Type 2017–2024 (USD Million)
Table 158 Asia Pacific: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 159 Asia Pacific: Anatomic Pathology Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 160 Asia Pacific: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 161 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 162 Japan: Market, By Product & Service, 2017–2024 (USD Million)
Table 163 Japan: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 164 Japan: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 165 Japan: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 166 Japan: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 167 Japan: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 168 Japan: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 169 Japan: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 170 Japan: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 171 Japan: Market, By End User, 2017–2024 (USD Million)
Table 172 China: Market, By Product & Service, 2017–2024 (USD Million)
Table 173 China: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 174 China: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 175 China: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 176 China: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 177 China: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 178 China: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 179 China: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 180 China: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 181 China: Market, By End User, 2017–2024 (USD Million)
Table 182 India: Market, By Product & Service, 2017–2024 (USD Million)
Table 183 India: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 184 India: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 185 India: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 186 India: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 187 India: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 188 India: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 189 India: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 190 India: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 191 India: Market, By End User, 2017–2024 (USD Million)
Table 192 RoAPAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 193 RoAPAC: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 194 RoAPAC: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 195 RoAPAC: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 196 RoAPAC: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 197 RoAPAC: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 198 RoAPAC: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 199 RoAPAC: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 200 RoAPAC: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 201 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 202 RoW: Market, By Region, 2017–2024 (USD Million)
Table 203 RoW: Market, By Product & Service, 2017–2024 (USD Million)
Table 204 RoW: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 205 RoW: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 206 RoW: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 207 RoW: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 208 RoW: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 209 RoW: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 210 RoW: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 211 RoW: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 212 RoW: Market, By End User, 2017–2024 (USD Million)
Table 213 Latin America: Market, By Product & Service, 2017–2024 (USD Million)
Table 214 Latin America: Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 215 Latin America: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 216 Latin America: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 217 Latin America: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 218 Latin America: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 219 Latin America: Market, By Application, 2017–2024 (USD Million)
Table 220 Latin America: Anatomic Pathology Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 221 Latin America: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 222 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 223 Middle East & Africa: Market, By Product & Service, 2017–2024 (USD Million)
Table 224 Middle East & Africa : Anatomic Pathology Services Market, By Type, 2017–2024 (USD Million)
Table 225 Middle East & Africa: Anatomic Pathology Instruments Market, By Type, 2017–2024 (USD Million)
Table 226 Middle East & Africa: Anatomic Pathology Consumables Market, By Type, 2017–2024 (USD Million)
Table 227 Middle East & Africa: Antibodies Market, By Type, 2017–2024 (USD Million)
Table 228 Middle East & Africa: Kits & Reagents Market, By Type, 2017–2024 (USD Million)
Table 229 Middle East & Africa: Anatomic Pathology Market, By Application, 2017–2024 (USD Million)
Table 230 Middle East & Africa: Market for Disease Diagnostics, By Type, 2017–2024 (USD Million)
Table 231 Middle East & Africa: Market for Cancer, By Type, 2017–2024 (USD Million)
Table 232 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)

List of Figures (35 Figures)

Figure 1 Anatomic Pathology Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Product & Service, 2019 Vs. 2024 (USD Million)
Figure 8 Anatomic Pathology Instruments Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 9 Anatomic Pathology Consumables Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 10 Anatomic Pathology Market, By Application, 2019 Vs. 2024 (USD Million)
Figure 11 Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 12 Market, By Region, 2019 Vs. 2024 (USD Million)
Figure 13 High Incidence of Cancer & Other Target Diseases to Drive Market Growth
Figure 14 Services Accounted for the Largest Share of the North American Anatomic Pathology Market in 2018
Figure 15 Countries in the Asia Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 16 Market: Drivers, Opportunities, Challenges, and Trends
Figure 17 Services to Continue to Dominate the Market During the Forecast Period
Figure 18 Disease Diagnostics Applications to Continue to Dominate the Market During the Forecast Period
Figure 19 Hospital Laboratories to Dominate the Market During the Forecast Period
Figure 20 North America Will Continue to Dominate the Market in 2024
Figure 21 North America: Market Snapshot
Figure 22 US: Cancer Statistics
Figure 23 Canada: Cancer Statistics
Figure 24 Key Developments in the Market Between 2016 and 2019
Figure 25 Market Evolution Framework
Figure 26 Anatomic Pathology Market Share Analysis, By Instrument and Consumable Provider, 2018
Figure 27 MnM Dive-Vendor Comparison Matrix: Market
Figure 28 Company Snapshot: F. Hoffmann-La Roche (2018)
Figure 29 Company Snapshot: Danaher (2018)
Figure 30 Company Snapshot: Thermo Fisher Scientific (2018)
Figure 31 Company Snapshot: Abcam PLC. (2018)
Figure 32 Company Snapshot: Hologic, Inc. (2018)
Figure 33 Company Snapshot: Agilent Technologies (2018)
Figure 34 Company Snapshot: Becton, Dickinson and Company (2018)
Figure 35 Company Snapshot: Merck KGaA (Life Sciences Segment) (2018)

★調査レポート[解剖病理学の世界市場予測:機器(組織処理システム、ミクロトーム)、消耗品(抗体)、組織病理学] ( Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) - Global Forecast to 2024 / MD5104) 販売に関する免責事項
[解剖病理学の世界市場予測:機器(組織処理システム、ミクロトーム)、消耗品(抗体)、組織病理学] ( Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) - Global Forecast to 2024 / MD5104) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆